DUBLIN--(BUSINESS WIRE)--The "Cell Line Development - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Global Cell Line Development Market to Reach $10.7 Billion by 2027 Amid the COVID-19 crisis, the global market for Cell Line Development estimated at US$4.7 Billion in the year 2020, is projected to reach a revised size of US$10.7 Billion by 2027, growing at a CAGR of 12.3% over the analysis period 2020-2027.

Equipment, one of the segments analyzed in the report, is projected to record a 12.5% CAGR and reach US$4.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Reagents & Media segment is readjusted to a revised 12.8% CAGR for the next 7-year period.

The U.S. Market is Estimated at $1.4 Billion, While China is Forecast to Grow at 11.8% CAGR

The Cell Line Development market in the U.S. is estimated at US$1.4 Billion in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$1.9 Billion by the year 2027 trailing a CAGR of 11.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.8% and 10.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 9% CAGR.

Accessories & Consumables Segment to Record 6.8% CAGR

In the global Accessories & Consumables segment, USA, Canada, Japan, China and Europe will drive the 6.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$242 Million in the year 2020 will reach a projected size of US$380.6 Million by the close of the analysis period.

China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1.3 Billion by the year 2027.

Select Competitors (Total 44 Featured):

• Abzena PLC
• American Type Culture Collection (ATCC)
• Apath LLC
• Bioceros
• Catalent, Inc.
• CELLforCURE
• Cobra Biologics
• Corning, Inc.
• Cyagen US Inc.
• Cytovance Biologics
• Epistem Holdings PLC
• EuBiologics Co., Ltd.
• GE Healthcare
• GVK Biosciences Private Limited
• Hitachi Chemical Advanced Therapeutics Solutions, LLC
• Lonza Group Ltd.
• MilliporeSigma
• NAEJA-RGM Pharmaceuticals, Inc.
• Paragon Bioservices, Inc.
• Patheon, Inc.
• Promocell GmbH
• Samsung BioLogics
• Sartorius AG
• Selexis SA
• Thermo Fisher Scientific, Inc.
• WuXi AppTec

For more information about this report visit https://www.researchandmarkets.com/r/lr5q8p

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900